Studies have shown that the levels of free PSA in the serum act as a more accurate marker for BPH, while the levels of α1-antichymotrypsin-PSA complex more accurately predict prostate cancer [5]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.